Difficulty: Medium
Average Score: 90%
Practice
Which drug should not be used to control secondary hypertension in a sexually active adolescent female who uses intermittent birth control?
Correct answer
C
Rationale
In this scenario, the correct answer is C) ACE inhibitors. ACE inhibitors are contraindicated in pregnancy due to their potential to cause fetal harm, especially in the second and third trimesters. Since the sexually active adolescent female is using intermittent birth control, there is a risk of pregnancy if she were to become pregnant while on ACE inhibitors, it could harm the fetus.
Beta blockers (option A) are generally considered safe for use in hypertension, but they may not be the best choice in this case due to their potential to mask certain symptoms of hypoglycemia, which could affect the efficacy of birth control.
Calcium channel blockers (option B) are also commonly used in treating hypertension, but they do not carry the same risks as ACE inhibitors in pregnancy.
Diuretics (option D) are another class of medications used in hypertension, but they do not pose the same risks in pregnancy as ACE inhibitors.
Educationally, this question highlights the importance of considering the individual patient's circumstances when selecting medications, especially in vulnerable populations like adolescents. It underscores the need for healthcare providers to be aware of potential drug interactions and contraindications to ensure safe and effective treatment.
Beta blockers (option A) are generally considered safe for use in hypertension, but they may not be the best choice in this case due to their potential to mask certain symptoms of hypoglycemia, which could affect the efficacy of birth control.
Calcium channel blockers (option B) are also commonly used in treating hypertension, but they do not carry the same risks as ACE inhibitors in pregnancy.
Diuretics (option D) are another class of medications used in hypertension, but they do not pose the same risks in pregnancy as ACE inhibitors.
Educationally, this question highlights the importance of considering the individual patient's circumstances when selecting medications, especially in vulnerable populations like adolescents. It underscores the need for healthcare providers to be aware of potential drug interactions and contraindications to ensure safe and effective treatment.